John J Davis - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

John J Davis

Showing results (11-20 of 30) with videos related to

Pageof 3

Sort By:

FEBS Letters|November 26, 2005

Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cellsFuminori Teraishi, Lidong Zhang, Wei Guo, et al.

Cancer Biology & Therapy|December 3, 2005

Downregulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cellsFengqin Dong, Wei Guo, Lidong Zhang, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 16, 2005

P-glycoprotein-independent apoptosis induction by a novel synthetic compound, MMPT [5-[(4-methylphenyl)methylene]-2-(phenylamino)-4(5H)-thiazolone]Fuminori Teraishi, Shuhong Wu, Jiichiro Sasaki, et al.

Frontiers in Sports and Active Living|June 7, 2021

Monitoring Gait Complexity as an Indicator for Running-Related Injury Risk in Collegiate Cross-Country Runners: A Proof-of-Concept StudyAllison H Gruber, James McDonnell, John J Davis, et al.

The Prostate|November 23, 2005

Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compoundFuminori Teraishi, Shuhong Wu, Satoshi Inoue, et al.

Journal of Biomechanics|April 27, 2026

Predicting Achilles tendon and patellofemoral joint forces during running with consumer-grade wearable sensor dataJohn J Davis, Stacey A Meardon, Andrew W Brown, et al.

Sensors (Basel, Switzerland)|May 11, 2024

Are Gait Patterns during In-Lab Running Representative of Gait Patterns during Real-World Training? An Experimental StudyJohn J Davis, Stacey A Meardon, Andrew W Brown, et al.

Cancer Biology & Therapy|August 6, 2005

Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulationHongbo Zhu, Wei Guo, Lidong Zhang, et al.

The Journal of Gene Medicine|October 9, 2003

Enhancing adenovirus-mediated gene transfer in vitro and in vivo by addition of protamine and hydrocortisoneTongyu Lin, Jian Gu, Lidong Zhang, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004

Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanismsHongbo Zhu, Lidong Zhang, Xuefeng Huang, et al.

Pageof 3

Search research articles

Showing results (11-20 of 30) with videos related to

Sort By:

Pageof 3

FEBS Letters|November 26, 2005

Activation of c-Jun NH2-terminal kinase is required for gemcitabine's cytotoxic effect in human lung cancer H1299 cellsFuminori Teraishi, Lidong Zhang, Wei Guo, et al.

Cancer Biology & Therapy|December 3, 2005

Downregulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cellsFengqin Dong, Wei Guo, Lidong Zhang, et al.

The Journal of Pharmacology and Experimental Therapeutics|April 16, 2005

Frontiers in Sports and Active Living|June 7, 2021

Monitoring Gait Complexity as an Indicator for Running-Related Injury Risk in Collegiate Cross-Country Runners: A Proof-of-Concept StudyAllison H Gruber, James McDonnell, John J Davis, et al.

The Prostate|November 23, 2005

Antitumor activity and downregulation of pro-angiogenic molecules in human prostate cancer cells by a novel thiazolidione compoundFuminori Teraishi, Shuhong Wu, Satoshi Inoue, et al.

Journal of Biomechanics|April 27, 2026

Predicting Achilles tendon and patellofemoral joint forces during running with consumer-grade wearable sensor dataJohn J Davis, Stacey A Meardon, Andrew W Brown, et al.

Sensors (Basel, Switzerland)|May 11, 2024

Are Gait Patterns during In-Lab Running Representative of Gait Patterns during Real-World Training? An Experimental StudyJohn J Davis, Stacey A Meardon, Andrew W Brown, et al.

Cancer Biology & Therapy|August 6, 2005

Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulationHongbo Zhu, Wei Guo, Lidong Zhang, et al.

The Journal of Gene Medicine|October 9, 2003

Enhancing adenovirus-mediated gene transfer in vitro and in vivo by addition of protamine and hydrocortisoneTongyu Lin, Jian Gu, Lidong Zhang, et al.

Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004

Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanismsHongbo Zhu, Lidong Zhang, Xuefeng Huang, et al.

Pageof 3